# Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/management-of-acquired-resistance-to-egfr-tki-targeted-therapy-in-advanced-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shang‐Gin Wu,Jin‐Yuan Shih |
| Citations | 829 |
| DOI | 10.1186/s12943-018-0777-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/s12943-018-0777-1 |
| OpenAlex ID | https://openalex.org/W2795708883 |
| PMID | 29455650 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Shang‐Gin Wu](https://scholariq.org/researchers/shang-gin-wu/)
- [Jin‐Yuan Shih](https://scholariq.org/researchers/jin-yuan-shih/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.